|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
affects response to substance affects transport |
ISO |
ABCB1A protein affects the susceptibility to Prazosin ABCB1A protein affects the transport of Prazosin ABCB1 protein affects the transport of Prazosin |
CTD |
PMID:15502009 PMID:15616150 PMID:18322075 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
affects response to substance |
ISO |
ABCB1B protein affects the susceptibility to Prazosin |
CTD |
PMID:15502009 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
multiple interactions increases export affects transport |
ISO |
3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester inhibits the reaction [ABCG2 protein results in increased export of Prazosin]; Elacridar inhibits the reaction [ABCG2 protein results in increased export of Prazosin] 6-OH-BDE-47 inhibits the reaction [ABCG2 protein results in increased export of Prazosin] ABCG2 protein affects the transport of Prazosin |
CTD |
PMID:18322075 PMID:19056916 PMID:28031414 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Phenylephrine results in increased expression of ACTA1 mRNA] |
CTD |
PMID:17592507 |
|
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Adora1 |
adenosine A1 receptor |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Phenylephrine results in increased expression of ADORA1 protein] |
CTD |
PMID:19966059 |
|
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
|
|
G |
Adora2a |
adenosine A2a receptor |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein] |
CTD |
PMID:19966059 |
|
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Adora3 |
adenosine A3 receptor |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Phenylephrine results in increased expression of ADORA3 protein] |
CTD |
PMID:19966059 |
|
NCBI chr 2:193,352,759...193,392,946
Ensembl chr 2:193,388,713...193,392,357
|
|
G |
Adra1a |
adrenoceptor alpha 1A |
multiple interactions affects binding increases expression decreases activity |
ISO EXP |
1-(2-(3-methoxyphenyl)ethyl)phenoxy-3-(dimethylamino)-2-propanol inhibits the reaction [Prazosin binds to ADRA1A protein]; alfuzosin inhibits the reaction [Prazosin binds to ADRA1A protein]; Epinephrine inhibits the reaction [ADRA1A protein binds to Prazosin]; Ketanserin inhibits the reaction [Prazosin binds to ADRA1A protein]; Norepinephrine inhibits the reaction [ADRA1A protein binds to Prazosin]; Oxymetazoline inhibits the reaction [ADRA1A protein binds to Prazosin]; Oxymetazoline inhibits the reaction [Prazosin binds to ADRA1A protein]; Prazosin binds to and results in decreased activity of ADRA1A protein; Prazosin inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in decreased transport of Potassium]; sarpogrelate inhibits the reaction [Prazosin binds to ADRA1A protein]; xylometazoline inhibits the reaction [ADRA1A protein binds to Prazosin] ADRA1A protein binds to Prazosin; Prazosin binds to ADRA1A protein Prazosin results in increased expression of ADRA1A mRNA; Prazosin results in increased expression of ADRA1A protein Prazosin binds to and affects the activity of ADRA1A protein; Prazosin binds to and results in decreased activity of ADRA1A protein; Prazosin inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; Prazosin inhibits the reaction [Norepinephrine results in increased activity of ADRA1A protein] Prazosin results in decreased activity of ADRA1A protein |
CTD |
PMID:6310690 PMID:7536677 PMID:8183249 PMID:8196478 PMID:9639061 PMID:10416824 PMID:11693201 PMID:11934817 PMID:11937776 PMID:12560108 PMID:15365637 PMID:15550506 PMID:15627480 PMID:15951348 PMID:16545797 PMID:20030735 More...
|
|
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
|
|
G |
Adra1b |
adrenoceptor alpha 1B |
multiple interactions increases expression affects binding |
ISO EXP |
1-(2-(3-methoxyphenyl)ethyl)phenoxy-3-(dimethylamino)-2-propanol inhibits the reaction [Prazosin binds to ADRA1B protein]; Epinephrine inhibits the reaction [ADRA1B protein binds to Prazosin]; Ketanserin inhibits the reaction [Prazosin binds to ADRA1B protein]; Norepinephrine inhibits the reaction [ADRA1B protein binds to Prazosin]; Oxymetazoline inhibits the reaction [ADRA1B protein binds to Prazosin]; sarpogrelate inhibits the reaction [Prazosin binds to ADRA1B protein]; xylometazoline inhibits the reaction [ADRA1B protein binds to Prazosin] Prazosin results in increased expression of ADRA1B protein Prazosin binds to and affects the activity of ADRA1B protein ADRA1B protein binds to Prazosin; Prazosin binds to ADRA1B protein |
CTD |
PMID:8183249 PMID:9639061 PMID:11934817 PMID:11937776 PMID:20030735 |
|
NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919
|
|
G |
Adra1d |
adrenoceptor alpha 1D |
multiple interactions affects binding |
ISO EXP |
1-(2-(3-methoxyphenyl)ethyl)phenoxy-3-(dimethylamino)-2-propanol inhibits the reaction [Prazosin binds to ADRA1D protein]; Epinephrine inhibits the reaction [ADRA1D protein binds to Prazosin]; Ketanserin inhibits the reaction [Prazosin binds to ADRA1D protein]; Norepinephrine inhibits the reaction [ADRA1D protein binds to Prazosin]; Oxymetazoline inhibits the reaction [ADRA1D protein binds to Prazosin]; sarpogrelate inhibits the reaction [Prazosin binds to ADRA1D protein]; xylometazoline inhibits the reaction [ADRA1D protein binds to Prazosin] ADRA1D protein binds to Prazosin; Prazosin binds to ADRA1D protein Prazosin binds to and affects the activity of ADRA1D protein |
CTD |
PMID:8183249 PMID:9294627 PMID:9639061 PMID:11937776 PMID:15493479 PMID:20030735 More...
|
|
NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354
|
|
G |
Adra2a |
adrenoceptor alpha 2A |
multiple interactions |
ISO EXP |
Prazosin inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRA2A protein]; Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein]] Prazosin binds to and results in decreased activity of ADRA2A protein |
CTD |
PMID:8397342 PMID:10742289 |
|
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Phenylephrine results in decreased expression of ATP2A2 mRNA] |
CTD |
PMID:11577024 PMID:17592507 |
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Avp |
arginine vasopressin |
increases expression |
EXP |
Prazosin results in increased expression of AVP protein |
CTD |
PMID:1791990 |
|
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
Prazosin results in increased activity of CASP8 protein |
CTD |
PMID:26449523 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
Prazosin results in increased activity of CASP9 protein |
CTD |
PMID:26449523 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
Prazosin inhibits the reaction [Norepinephrine results in increased secretion of CCL5 protein] |
CTD |
PMID:16782692 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of CREB1 protein] |
CTD |
PMID:15522277 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
Prazosin promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA] Prazosin results in increased expression of CYP1A1 mRNA |
CTD |
PMID:15627480 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]]; Prazosin promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Prazosin promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] |
CTD |
PMID:16510159 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [EDN1 protein results in increased expression of NPPA protein]; Prazosin inhibits the reaction [Phenylephrine results in increased expression of EDN1 protein] |
CTD |
PMID:12513686 PMID:15007106 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
[Norepinephrine co-treated with Prazosin] results in decreased expression of FN1 protein |
CTD |
PMID:11821714 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO EXP |
Prazosin inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of FOS protein] Prazosin inhibits the reaction [Amphetamine results in increased expression of FOS protein]; Prazosin inhibits the reaction [Norepinephrine results in increased expression of FOS mRNA] |
CTD |
PMID:12560108 PMID:12955385 PMID:19225867 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Norepinephrine results in increased activity of G6PD protein]; Prazosin inhibits the reaction [norfenefrine results in increased activity of G6PD protein] |
CTD |
PMID:1378361 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
ISO |
Prazosin inhibits the reaction [Acetaminophen results in increased expression of GCLC mRNA] |
CTD |
PMID:18071297 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
Prazosin inhibits the reaction [Acetaminophen results in increased expression of HMOX1 mRNA] |
CTD |
PMID:18071297 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [IGF1 protein results in decreased susceptibility to Norepinephrine] |
CTD |
PMID:17184500 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of JUN mRNA] |
CTD |
PMID:19225867 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Norepinephrine results in decreased secretion of and results in decreased expression of LHB protein] |
CTD |
PMID:3953791 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lpl |
lipoprotein lipase |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of LPL mRNA] |
CTD |
PMID:9032464 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions affects activity |
ISO EXP |
Prazosin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] Prazosin affects the reaction [Norepinephrine results in increased activity of and results in increased phosphorylation of MAPK1 protein]; Prazosin inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; Prazosin inhibits the reaction [Phenylephrine results in increased activity of MAPK1 protein]; Prazosin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] Prazosin affects the activity of MAPK1 protein |
CTD |
PMID:11693273 PMID:11804996 PMID:11880281 PMID:12513686 PMID:17306214 PMID:18445782 PMID:20434527 More...
|
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
affects activity multiple interactions |
EXP ISO |
Prazosin affects the activity of MAPK3 protein Prazosin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein] Prazosin inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; Prazosin inhibits the reaction [Phenylephrine results in increased activity of MAPK3 protein]; Prazosin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:11693273 PMID:11804996 PMID:11880281 PMID:12513686 PMID:17306214 PMID:18445782 More...
|
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of MMP2 mRNA] |
CTD |
PMID:15326086 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Myh6 |
myosin heavy chain 6 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Phenylephrine results in decreased expression of MYH6 mRNA] |
CTD |
PMID:11577024 PMID:17592507 |
|
NCBI chr15:28,418,120...28,442,316
Ensembl chr15:28,417,616...28,441,720
|
|
G |
Myh7 |
myosin heavy chain 7 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA] |
CTD |
PMID:11577024 PMID:17592507 |
|
NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Cocaine results in increased phosphorylation of NCF1 protein] |
CTD |
PMID:15936005 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
decreases activity |
ISO |
Prazosin results in decreased activity of NFE2L2 protein |
CTD |
PMID:30203046 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO EXP |
Prazosin inhibits the reaction [carvedilol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitrites]]; Prazosin inhibits the reaction [carvedilol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; Prazosin inhibits the reaction [Dopamine inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitrites]]; Prazosin inhibits the reaction [Dopamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; Prazosin inhibits the reaction [Epinephrine inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitrites]]; Prazosin inhibits the reaction [Epinephrine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; Prazosin inhibits the reaction [Norepinephrine inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitrites]]; Prazosin inhibits the reaction [Norepinephrine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] Prazosin inhibits the reaction [Phenylephrine results in increased expression of NOS2 mRNA]; Prazosin inhibits the reaction [Phenylephrine results in increased expression of NOS2 protein] |
CTD |
PMID:15753950 PMID:19439816 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions |
EXP |
Prazosin inhibits the reaction [EDN1 protein results in increased expression of NPPA protein]; Prazosin inhibits the reaction [Norepinephrine results in increased expression of NPPA mRNA]; Prazosin inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Prazosin inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] |
CTD |
PMID:12513686 PMID:15240149 PMID:16714034 PMID:17592507 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Npy |
neuropeptide Y |
multiple interactions |
EXP |
[Prazosin co-treated with SCH 23390] inhibits the reaction [Phenylpropanolamine results in decreased expression of NPY protein] |
CTD |
PMID:21989786 |
|
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Oxt |
oxytocin/neurophysin I prepropeptide |
increases expression |
EXP |
Prazosin results in increased expression of OXT protein |
CTD |
PMID:1791990 |
|
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
|
|
G |
Plcb1 |
phospholipase C beta 1 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of and results in increased activity of PLCB1 protein]; Prazosin inhibits the reaction [Norepinephrine results in increased expression of PLCB1 mRNA]; Prazosin inhibits the reaction [Norepinephrine results in increased expression of PLCB1 protein] |
CTD |
PMID:16714034 PMID:19225867 |
|
NCBI chr 3:122,059,988...122,772,896
Ensembl chr 3:122,060,031...122,772,869
|
|
G |
Plcb3 |
phospholipase C beta 3 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of and results in increased activity of PLCB3 protein]; Prazosin inhibits the reaction [Norepinephrine results in increased expression of PLCB3 mRNA]; Prazosin inhibits the reaction [Norepinephrine results in increased expression of PLCB3 protein] |
CTD |
PMID:16714034 PMID:19225867 |
|
NCBI chr 1:204,143,257...204,160,384
Ensembl chr 1:204,144,956...204,160,228
|
|
G |
Plcd1 |
phospholipase C, delta 1 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of and results in increased activity of PLCD1 protein]; Prazosin inhibits the reaction [Norepinephrine results in increased expression of PLCD1 mRNA]; Prazosin inhibits the reaction [Norepinephrine results in increased expression of PLCD1 protein] |
CTD |
PMID:16714034 PMID:19225867 |
|
NCBI chr 8:118,795,196...118,818,186
Ensembl chr 8:118,795,201...118,818,186
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of and results in increased activity of PLCG1 protein]; Prazosin inhibits the reaction [Norepinephrine results in increased expression of PLCG1 mRNA]; Prazosin inhibits the reaction [Norepinephrine results in increased expression of PLCG1 protein] |
CTD |
PMID:16714034 PMID:19225867 |
|
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions |
ISO |
[Propranolol co-treated with Prazosin] inhibits the reaction [Norepinephrine results in increased expression of PPARGC1A mRNA] |
CTD |
PMID:16513826 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ren |
renin |
decreases activity increases activity multiple interactions increases transport |
ISO EXP |
Prazosin results in decreased activity of REN protein Prazosin results in increased activity of REN protein Propranolol inhibits the reaction [Prazosin results in increased transport of REN protein] |
CTD |
PMID:3539430 PMID:6173514 PMID:6258839 PMID:7023672 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB1 protein] |
CTD |
PMID:12720544 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Rps6kb2 |
ribosomal protein S6 kinase B2 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein] |
CTD |
PMID:12720544 |
|
NCBI chr 1:201,451,265...201,458,096
Ensembl chr 1:201,451,265...201,458,078
|
|
G |
Shc1 |
SHC adaptor protein 1 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Norepinephrine results in increased phosphorylation of SHC1 protein alternative form] |
CTD |
PMID:19168439 |
|
NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
decreases activity multiple interactions |
ISO |
Prazosin results in decreased activity of SLC22A1 protein Prazosin inhibits the reaction [SLC22A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:12110607 |
|
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Prazosin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc22a3 |
solute carrier family 22 member 3 |
multiple interactions decreases activity |
ISO |
Prazosin inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] Prazosin results in decreased activity of SLC22A3 protein |
CTD |
PMID:12110607 |
|
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
|
|
G |
Spn |
sialophorin |
decreases response to substance |
ISO |
SPN protein results in decreased susceptibility to Prazosin |
CTD |
PMID:18711009 |
|
NCBI chr 1:181,746,937...181,759,564
Ensembl chr 1:181,746,429...181,759,628
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of TGFB1 mRNA] |
CTD |
PMID:15326086 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of TGFB2 mRNA] |
CTD |
PMID:15326086 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgfb3 |
transforming growth factor, beta 3 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of TGFB3 mRNA] |
CTD |
PMID:15326086 |
|
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of TIMP2 mRNA] |
CTD |
PMID:15326086 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions |
ISO |
Prazosin inhibits the reaction [Phenylephrine results in increased expression of TNFSF11 mRNA] |
CTD |
PMID:17306214 |
|
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Tyr |
tyrosinase |
multiple interactions |
EXP |
Prazosin inhibits the reaction [Phenylephrine results in increased activity of TYR protein] |
CTD |
PMID:15278367 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|